皮肤状细胞癌的突变概况,具有来自头部和部区域的不同临床侵略模式
Maria Colombino1, Giuseppe Palmieri2, Manuela Rodio3,4
1Institute of Genetic and Biomedical Research (IRGB), National Research Council (CNR), 07100 Sassari, Italy.
Cancers
|June 19, 2024
概括
这项研究研究了皮肤状细胞癌 (cSCC) 的遗传突变. 在非复发的cSCC患者中,更高的突变率可能会增强免疫反应,从而可能防止复发.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 皮肤状细胞癌 (cSCC) 是一种常见的癌症,发病率不断增加,突变率高.
- 了解cSCC的遗传情景对于开发向疗法至关重要,特别是对于高风险患者.
- 以前的研究表明,基因突变和癌症进展之间存在联系,但cSCC中的特定预后标志物仍然难以捉摸.
研究的目的:
- 使用病例对照设计,识别头部和部皮肤状细胞癌 (cSCC) 中经常发生突变的基因.
- 探索突变概况与pT2阶段cSCC疾病复发之间的潜在相关性.
- 调查一个更高的突变负担可能会影响免疫性和疾病结果的假设.
主要方法:
- 追溯病例控制研究涉及两个队列 (发现:14名患者,验证:12名患者) 的pT2阶段头部/部cSCC.
- 下一代测序 (NGS) 在组织学样本上进行,以分析基因突变.
- 为了进行比较分析,患者被分为"病例" (早期局部复发) 和"对照" (没有复发).
主要成果:
- 在研究的cSCC队列中,TP53和CDKN2A被确定为最常发生突变的基因.
- 没有发现任何特定突变是最终的预后或治疗标.
- 对照组 (非复发) 与病例 (复发) 相比,总体突变率更高的趋势.
结论:
- 该研究强调TP53和CDKN2A是头部和部cSCC中常见的突变基因.
- 在cSCC中更高的突变率可能会增加瘤免疫性,促进免疫识别,并可能防止复发.
- 需要进一步的研究来探索cSCC中的基因突变对治疗策略的免疫调节效应.
更多相关视频
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.8K
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
9.6K
相关概念视频
01:30Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K